SAFE

No contraindications
Medical device class IIa (EU MDD)


SPECIFIC

Extracorporeal endotoxin elimination in hemoperfusion


EFFECTIVE

Results in 2 hours
1 treatment = 1 adsorber 


Take endotoxin out of the picture!

Endotoxin removal in COVID-19

Removes endotoxin – safely, effectively and easily

Alteco LPS Adsorber

The Alteco LPS Adsorber removes endotoxin safely, effectively and easily in both acute and planned situations.

Quick and easy to use in critical situations

The Alteco LPS Adsorber is quick to prepare and easy to use which is crucial in critical situations. The process is effective without requiring extra investment and has a rapid onset of action.

A proactive tool in cardiac surgery

The Alteco LPS Adsorber can be a lifesaver and should be used as a proactive tool to avoid life-threatening situations. By implementing the adsorber in the heart- and lung machine during surgery, organ damage and postoperative complications due to high levels of endotoxin can be avoided, paving the way for a faster recovery.

News and events

Alteco Medical has signed a distributor agreement with B.Braun Medical SA, Spain.
Alteco Medical has signed a new distributor agreement with Adsorpio UG, covering the German market.
Bacterial translocation from GI-tract might complicate severe COVID-19. Bacterial products might be another possible contributor to the cytokine storm.
Jakub Smiechowicz, Barbara Adamik, Department of Anesthesiology and Intensive Therapy, Wroclaw Medical University, Poland
Webinar: Selective adsorption therapies - adsorption of gram-negative endotoxins (in Portugese)
Sweden’s innovation agency Vinnova grants Alteco Medical funding for innovation project.

When endotoxins are a threat or a problem, then the Alteco LPS Adsorber is the solution.

Be prepared for the worst from the start

High levels of endotoxin activity are associated with organ failure and death. Therefore, starting treatment early is important.

Removing endotoxin rapidly stabilizes the patient

The device produces rapid results when required and usually only one treatment is needed. The optimized blood contact area reduces immune activation. It rapidly stabilizes the patient by removing the endotoxin and is a positive tool for helping the immune system to act on its own.

Contact Alteco Medical for more information.

+46 46 32 86 00

info@altecomed.com

Get the latest updates

    Did you know?

    …that endotoxin is one of the most potent bacterial inducers of cytokines?


    …that surgery with long clamping time increase the risk of endotoxemia?


    …that endotoxin can cause coagulation disturbances and sepsis in COVID-19 patients?

    …that someone dies from sepsis every 2.8 seconds?

    …that sepsis kills more people than cancer?


    …that gram-negative bacteria contain endotoxin (LPS) and can cause sepsis, blood clotting, renal failure, organ failure and even death?


    …that gram-negative bacteria are increasingly resistant to antibiotics?


    …that removing endotoxin in the patient’s bloodstream can stabilize the patient?


    …that ECMO and CPB are risk factors for endotoxemia?


    …that cancer, burns, trauma and liver failure are associated with endotoxemia?


    …that hospitalization is the most common risk factor for gram-negative bacterial infections?


    …that high endotoxin activity predicts longer ICU and hospital stays?


    …that haemoperfusion is an extracorporeal treatment to remove toxic substances (such as endotoxin) from the patient’s blood?


    …that ventilator-associated pneumonia is often caused by gram-negative bacteria?


    …that 50% of COVID-19 patients who have died had sepsis due to secondary bacterial infections?


    …that COVID-19 patients can suffer from life-threatening cytokine storms due to overreactions in the immune system?


    …that removing endotoxin (LPS) may calm cytokine storms in COVID-19 patients?


    …that sepsis is responsible for one in every five deaths worldwide – about 11 million deaths every year?